This report contains market size and forecasts of Dipine Antihypertensive Drugs in global, including the following market information:
- Global Dipine Antihypertensive Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Dipine Antihypertensive Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Dipine Antihypertensive Drugs companies in 2021 (%)
The global Dipine Antihypertensive Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nifedipine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dipine Antihypertensive Drugs include Johnson & Johnson, Merck & Co., Inc., NOVARTIS, Astrazeneca, Bayer, Kyowa Hakko Kogyo, Zuventus Health care ltd, JB Chemicals and Pharmaceuticals Ltd and Boehringer Ingelheim, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dipine Antihypertensive Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dipine Antihypertensive Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dipine Antihypertensive Drugs Market Segment Percentages, by Type, 2021 (%)
- Nifedipine
- Amlodipine Besylate
- Felidipine
- Benidipine
- Other
Global Dipine Antihypertensive Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dipine Antihypertensive Drugs Market Segment Percentages, by Application, 2021 (%)
Global Dipine Antihypertensive Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dipine Antihypertensive Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Dipine Antihypertensive Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Dipine Antihypertensive Drugs revenues share in global market, 2021 (%)
- Key companies Dipine Antihypertensive Drugs sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Dipine Antihypertensive Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Johnson & Johnson
- Merck & Co., Inc.
- NOVARTIS
- Astrazeneca
- Bayer
- Kyowa Hakko Kogyo
- Zuventus Health care ltd
- JB Chemicals and Pharmaceuticals Ltd
- Boehringer Ingelheim
- GSK
- Daiichi-Sankyo
- fujipharma
